360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

National Institute of Allergy and Infectious Diseases

Type: Organization

Name: National Institute of Allergy and Infectious Diseases

Nationality: United States

Fact Sheet: Fact Sheet for National Institute of Allergy an...

First reported 3 hours ago - Updated 12 mins ago - 1 reports

National Institute of Allergy and Infectious Diseases

New MERS virus spreads easily, deadlier than SARS

This undated electron microscope image made availalbe by the National Institute of Allergy and Infections Diseases - Rocky Mountain Laboratories shows novel coronavirus particles, also known as the MERS virus, colorized in yellow. The mysterious new respiratory ... [Published Santa Maria Times - 3 hours ago]

Entities: Severe Acute Respiratory Syndrome, Virus, National Institute of Allergy and Infectious Di...

First reported Jun 18 2013 - Updated Jun 18 2013 - 1 reports

YSPH researcher will help direct major clinical research network on antibacterial resistance

Research Network on Antibacterial Resistance FundedMonday, June 17, 2013By Michael GreenwoodFeatured Infectious Diseases YSPH NewsYSPH Researcher Will Serve on Steering Committee for Multimillion-Dollar InitiativeA researcher from the will help direct ... [Published Yale University - Jun 18 2013]

Entities: Bactericide, infections, National Institute of Allergy and Infectious Di..., Antibiotic

First reported Jun 18 2013 - Updated Jun 18 2013 - 1 reports

National institutes of Health

Isotechnika receives NRC funding for NICAM program

Isotechnika Pharma Inc. has received additional funding from the National Research Council Industrial Research Assistance Program for its non-immunosuppressive cyclophilin antagonist molecules program.NRC-IRAP continues to play an instrumental role in ... [Published Stockwatch - Jun 18 2013]

Entities: National institutes of Health, National Institute of Allergy and Infectious Di..., Scripps Research Institute, Industrial Research Limited

First reported Jun 15 2013 - Updated Jun 15 2013 - 1 reports

Oseltamivir

Double dose of antiviral drug offers no added benefit in severe influenza

(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- Giving double doses of the antiviral drug oseltamivir, or Tamiflu, offers no clinical or virological advantages over a standard dose for patients admitted to hospital with severe ... [Published NewsRX - Jun 15 2013]

Entities: Influenza, Oseltamivir, Infection, National Institute of Allergy and Infectious Di..., Wellcome Trust

First reported Jun 14 2013 - Updated Jun 14 2013 - 1 reports

Centers for Disease Control and Prevention

Recent HIV/AIDS News from CDC, FDA, and NIAID

June 12, 2013: Study Finds First Evidence That PrEP Can Reduce HIV Risk Among People Who Inject Drugs“A daily dose of a medication used to treat HIV infection reduced the risk of HIV acquisition among people who inject drugs by 49 percent. Those who took ... [Published AIDSinfo At-a-Glance: Offering Information on H ... - Jun 14 2013]

Entities: HIV/AIDS, National Institute of Allergy and Infectious Di..., Centers for Disease Control and Prevention, FDA Food & Drug Administration, immunodeficiency

First reported Jun 14 2013 - Updated Jun 14 2013 - 1 reports

Phase II

Tunitas Therapeutics Awarded Phase II SBIR Grant to Advance Asthma Program

(NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Tunitas Therapeutics, Inc., a private company discovering and developing novel human fusion proteins for the treatment of asthma and other allergic diseases, has been awarded ... [Published NewsRX - Jun 14 2013]

Entities: Therapeutics, Phase II, Asthma, National Institute of Allergy and Infectious Di...

First reported Jun 13 2013 - Updated Jun 13 2013 - 1 reports

Tenofovir

We Can (Kinda) Prevent Drug Users From Getting HIV

A commonly used antiretroviral pill can stop this from happening. Photo: NIAID.A once-a-day antiretroviral pill can cut HIV transmission in drug users by up to 70 percent, according to a major new study.The drug, Tenofovir, is already in common use as ... [Published Motherboard Magazine - Jun 13 2013]

Entities: HIV/AIDS, Tenofovir, Drugs

First reported Jun 13 2013 - Updated Jun 13 2013 - 1 reports

Duke to co-lead NIH research network on antibacterial resistance

DURHAM, N.C. -- Investigators at Duke Medicine and the University of California, San Francisco (UCSF) have been selected to oversee a nationwide research program on antibacterial resistance, which includes a focus on the growing unmet challenges associated ... [Published Bio-Medicine - Jun 13 2013]

Entities: Bactericide, National institutes of Health, Antibiotic, National Institute of Allergy and Infectious Di...

First reported Jun 05 2013 - Updated Jun 06 2013 - 6 reports

Researchers Discover How HIV Integration into T-Cells Triggers Cell Death

Category: HIV Basic ScienceWritten by NIAIDViral integration into CD4 T-cells triggers host cell death by activating DNA-dependent protein kinase (DNA-PK), according to study findings published in the June 5, 2013, advance online edition of Nature. Learning ... [Published HIV and Hepatitis.com - Jun 06 2013]

Entities: HIV/AIDS, T-cells, National Institute of Allergy and Infectious Di..., National institutes of Health

First reported Jun 03 2013 - Updated Jun 04 2013 - 6 reports

Duke Medicine, UCSF investigators to oversee research program on antibacterial resistance

Investigators at Duke Medicine and the University of California, San Francisco (UCSF) have been selected to oversee a nationwide research program on antibacterial resistance, which includes a focus on the growing unmet challenges associated with methicillin-resistant ... [Published News-Medical.Net - Jun 04 2013]

Entities: Bactericide, National Institute of Allergy and Infectious Di..., Vance Fowler

First reported Jun 02 2013 - Updated Jun 02 2013 - 2 reports

Pluristem to Present at FDA Symposium

- Pluristem Therapeutics Inc. (NASDAQCM: PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the company has been invited to present at the U.S. Food & Drug Administration's (FDA) Medical Countermeasures initiative ... [Published Noodls - Jun 02 2013]

Entities: National Institute of Allergy and Infectious Di..., FDA Food & Drug Administration, ARS++

First reported May 22 2013 - Updated May 23 2013 - 5 reports

Protein Fusion May Yield Universal Influenza Vaccination

A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine concept, which was developed by scientists ... [Published Bioscience Technology Online - May 23 2013]

Entities: Influenza, Vaccine, Protein

Quotes

"Our tool should help scientists better understand the relationship between viral structure and packaging, making it easier to develop antiviral agents as well as aid the redesign of viruses for use in gene therapy and drug delivery." The work was supported by NIH NIAID grant number R01AI080791 and NSF XSEDE grant number TG-MCB09

Computer modeling technique goes viral at Brandeis [Published EurekAlert! - Jun 18 2013]

...Robert Foster. "We are excited to work with the Scripps Research Institute, and Dr. Gallay in particular, as we continue to advance preclinical development of those NICAMs with the best potential to expand orally administered HCV treatment options for a broader population of patients."

Isotechnika receives NRC funding for NICAM program [Published Stockwatch - Jun 18 2013]

"This is the first evidence that pre-exposure prophylaxis (PrEP) offers significant protection to individuals exposed to HIV through injection drug use. The findings were published online today in the Lancet.”"

Recent HIV/AIDS News from CDC, FDA, and NIAID [Published AIDSinfo At-a-Glance: Offering Information on H... - Jun 14 2013]

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said, "The real important advance here is the proof of concept that in yet another high risk group - IV-drug users - pre-exposure prophylaxis can work if the individuals adhere to taking the drug." The study found that the reduction rate for those who took their daily dose routinely was even higher - 74%

New pill could prevent HIV infections [Published CNN - Jun 14 2013]

More Content

sort by: Date \| Relevance
Coronavirus Mystifies Scientists Seeing SARS-Li... [Published Bloomberg - 3 hours ago]
New MERS virus spreads easily, deadlier than SARS [Published Santa Maria Times - 3 hours ago]
Women Underrepresented in Antiretroviral Clinic... [Published The AIDS Reader - 10 hours ago]
Miller School Experts Suggest Broader Definitio... [Published Health Canal - Jun 19 2013]
Computer modeling technique goes viral at Brandeis [Published EurekAlert! - Jun 18 2013]
YSPH researcher will help direct major clinical... [Published Yale University - Jun 18 2013]
Isotechnika receives NRC funding for NICAM program [Published Stockwatch - Jun 18 2013]
Food Allergy Research & Education (FARE) Partne... [Published PRWeb - Jun 17 2013]
Comprehensive Assessment of HIV Target Cells in... [Published JAIDS - Jun 15 2013]
Double dose of antiviral drug offers no added b... [Published NewsRX - Jun 15 2013]
Recent HIV/AIDS News from CDC, FDA, and NIAID [Published AIDSinfo At-a-Glance: Offering Information on H ... - Jun 14 2013]
New pill could prevent HIV infections [Published CNN - Jun 14 2013]
Tunitas Therapeutics Awarded Phase II SBIR Gran... [Published NewsRX - Jun 14 2013]
Old Bones Give Clues to Leprosy’s Demise in Europe [Published Health.com - Jun 13 2013]
30 Years of HIV: Long Road Ahead to a Cure [Published HIV and Hepatitis.com - Jun 13 2013]
Old Bones Give Clues to Leprosy's Demise in Europe [Published Health Finder - Jun 13 2013]
We Can (Kinda) Prevent Drug Users From Getting HIV [Published Motherboard Magazine - Jun 13 2013]
Bananas as Hepatitis B Oral Vaccine? [Published The Guardian Express - Jun 13 2013]
Duke to co-lead NIH research network on antibac... [Published Bio-Medicine - Jun 13 2013]
St. Catharines teen puts hope in U.S. Lyme dise... [Published Fort Erie Times - Jun 13 2013]
Drug reduces HIV risk for drug users by 49 percent [Published stuff.co.nz - Jun 12 2013]
Helping prevent HIV in IV drug users [Published WDSU New Orleans - Jun 12 2013]
Fitch Affirms Montgomery County, MD's GOs at 'A... [Published Individual.com - Jun 12 2013]
Once-a-day pill prevents HIV in drug users [Published NBCNews.com - Jun 12 2013]
Gilead’s Viread Reduces HIV Risk for Drug Users... [Published Bloomberg - Jun 12 2013]
Move Over, Grandma: Why Kids Should Be the Prio... [Published Yahoo! News - Jun 12 2013]
Interfacial Cavity Filling To Optimize CD4–Mim... [Published Journal of Medicinal Chemistry - Jun 12 2013]
Chlamydia protein has an odd structure, scienti... [Published EurekAlert! - Jun 11 2013]
US Federal Business Opportunity: Department of ... [Published ITbriefing - Jun 11 2013]
FDA Approves Sanofi's 4-Strain Influenza Vaccine [Published Medical News Today - Jun 11 2013]

Blogs

sort by: Date \| Relevance
Recent HIV/AIDS News from CDC, FDA, and NIAID [Published AIDSinfo At-a-Glance: Offering Information on H ... - Jun 14 2013] June 12, 2013: Study Finds First Evidence That PrEP Can Reduce HIV Risk Among People Who Inject Drugs“A daily dose of a medication used to treat HIV infection reduced the risk of HIV acquisition among people who inject drugs by 49 percent. Those who took ...
Tunitas wins SBIR phase II grant to progress as... [Published PBR - News - Jun 05 2013] Tunitas Therapeutics has won a small business innovation research (SBIR) phase II grant worth $3m from the National Institute of Allergy and Infectious Disease (NIAID) to advance asthma program. ...
Gordon to be honored for microbiome studies [Published WUSTL Medicine & Healthcare News - Jun 04 2013] Jeffrey I. Gordon, MD, director of the Center for Genome Sciences and Systems Biology at Washington University School of Medicine in St. Louis, has been named the 2013 recipient of the Robert Koch Award. The award is widely regarded as the leading ...
Updated AIDSinfo Drug Database Offers Health Pr... [Published AIDSinfo At-a-Glance: Offering Information on H ... - May 31 2013] The latest additions to the AIDSinfo drug database provide health care providers and patients with even more information on HIV/AIDS-related drugs. Recent improvements to the database include: Investigational HIV drug summaries for health professionals ...
Salmonella uses protective switch during infection [Published PNNL News Center - Recent News Releases from Pa ... - May 27 2013] For the first time, researchers have found a particular kind of molecular switch in the food poisoning bacteria Salmonella Typhimurium under infection-like conditions. This switch, using a process called S-thiolation, appears to be used by the bacteria ...

Audio/Video

sort by: Date \| Relevance
HIV-infected infant cured [Published CBS News Online - YouTube - Mar 04 2013]
Scientists to Resume Testing on Human-to-Human ... [Published FOX Business - Video - Jan 28 2013]
Why this season’s flu is so virulent [Published Reuters Video: Top News - Jan 16 2013]
Worst flu season in a decade [Published CNN.com - Video - Jan 11 2013]
Flu outbreak spreading throught U.S. [Published CNN.com - Video - Jan 11 2013]

Press Releases

sort by: Date \| Relevance
HepB Fndn Honors Dr. Purcell Fmr Ch. of Hepatit... [Published PR.com Press Releases - Jun 01 2013]
Sorrento Therapeutics, Inc. announces its appro... [Published Financial Services - May 17 2013]
Inovio Pharmaceuticals & U.S. Army Receive $3.5... [Published Auto & Transportation - Apr 10 2013]
CEL-SCI Corporation Announces That NIAID Collab... [Published Business Wire Health News - Apr 08 2013]
VaxInnate Awarded U.S. Government Grant to Deve... [Published Business Wire Health News - Apr 04 2013]